PT - JOURNAL ARTICLE ED - , TI - EMA suspends licence for ingenol mebutate (Picato) AID - 10.1136/dtb.2020.000012 DP - 2020 Apr 01 TA - Drug and Therapeutics Bulletin PG - 51--51 VI - 58 IP - 4 4099 - http://dtb.bmj.com/content/58/4/51.short 4100 - http://dtb.bmj.com/content/58/4/51.full SO - Drug Ther Bull2020 Apr 01; 58 AB - Overview of: Medicines and Healthcare products Regulatory Agency. Ingenol mebutate gel (Picatoâ–¼): suspension of the licence due to risk of skin malignancy. Drug Safety Update 2020;13(7):1.